EXJADE 250mg

DCI: DEFERASIROXUM

Forma farmaceutică: COMPR. DISP.

Concentrația

250mg

Prescripție:

PR

Cod ATC

V03AC03

Firma / țara producătoare APP

NOVARTIS PHARMA GMBH - GERMANIA

Firma / țara deținătoare APP

NOVARTIS EUROPHARM LIMITED - IRLANDA

Volum ambalaj

-

Informații despre produs

  • Acțiune terapeutică:

    ALTE PREPARATE TERAPEUTICE CHELATORI DE FER

  • Ambalaj:

    • Cutie x 28 compr. disp. (blist. PVC/PE/PVDC/Al)
    • Cutie x 84 compr. disp. (blist. PVC/PE/PVDC/Al)
    • Cutie x 252 compr. disp. (blist. PVC/PE/PVDC/Al)

  • Nr. / data ambalaj APP

    • 356/2006/03
    • 356/2006/04
    • 356/2006/08

  • Valabilitate ambalaj

    3 ani

  • Cod CIM

    • W64441001
    • W64441002
    • W64441003

Partajează

Descarca

ProspectRezumatAmbalaj

Resurse suplimentare:

DEFERASIROX ACCORD 180 mg - ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIADEFERASIROX ACCORD 360 mg - ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIADEFERASIROX MSN LABORATORIES 180 mg - WESSLING HUNGARY KFT - UNGARIADEFERASIROX MSN LABORATORIES 360 mg - WESSLING HUNGARY KFT - UNGARIADEFERASIROX MSN LABORATORIES 90 mg - WESSLING HUNGARY KFT - UNGARIA